In recent years, CBD has become popular for those seeking natural solutions for various health concerns, such as stress and anxiety reduction, pain management,...
The first marijuana bill of the new Congress has been introduced.Cannabis stocks in the United States and Canada typically rise when legal reforms are...
The MMJ trifecta of firms, in partnership with a specialized pharmaceutical soft gelatin production firm, has completed production of its CBD, THC capsule medicine...
On December 9, 2022, the New York Office of Cannabis Management (OCM) released Cannabis Delivery Guidance allowing retail dispensaries, including Adult-Use Retail Dispensary (CAURD) licensees,...
On Friday, December 2, 2022, the White House announced that President Biden signed House Resolution 8454, into law:H.R. 8454, the “Medical Marijuana and Cannabidiol Research Expansion Act,”...
Friday, December 2, 2022
Key Takeaways
What Happened: After unanimous consent from the Senate, President Biden signed into law the Medical Marijuana and Cannabidiol Research Expansion Act, an...
The National Institute on Drug Abuse (NIDA), which is the leading federal agency that is in charge of research on drugs including cannabis, as well as any effects they may have, just expressed interest in federally funded studies on the various consumption methods and regulatory frameworks in the United States.